Rajesh Krishnan
Chief Tech/Sci/R&D Officer at ONCTERNAL THERAPEUTICS, INC.
Net worth: 19 809 $ as of 2024-03-30
Profile
Rajesh Krishnan is currently the Chief Technology Officer at Oncternal Therapeutics, Inc. Prior to his current position, he held the role of Head-Biologics Drug Substance Process Development at Gilead Sciences, Inc. from 2012 to 2017.
He also served as the VP-Process Development & Manufacturing Sciences at Dynavax Technologies Corp.
from 2018 to 2019.
Dr. Krishnan completed his undergraduate degree at Princeton University and holds graduate and doctorate degrees from the University of California, Davis.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-13 | 2,201 ( 0.07% ) | 19 809 $ | 2024-03-30 |
Rajesh Krishnan active positions
| Companies | Position | Start |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Rajesh Krishnan
| Companies | Position | End |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 2018-12-31 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2016-12-31 |
Training of Rajesh Krishnan
| Princeton University | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Rajesh Krishnan
